Suchergebnisse - "Mineur, Laurent"

PubPharm (140)

1

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

2

NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) Followed by Chemoradiation Based 5FU and Oxaliplatin and Surgery

enthalten in: Cancer research and treatment | 2024

von Mineur, L. | Plat, F. | Desseigne, F. | +9

3

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

4

The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation : Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750)

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2023

von Sun Myint, A. | Rao, C. | Barbet, N. | +10

5

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Rasola, C. | Laurent-Puig, P. | André, T. | +13

6

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Taïeb, J. | Bouche, O. | André, T. | +77

7

Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Mineur, L. | Vazquez, L. | Belkacemi, M. | +4

8

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Boige, V. | Blons, H. | François, E. | +20

CommentIn: JAMA Netw Open. 2023 Sep 5;6(9):e2333488. - PMID 37721757

9

OPERA : perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel

enthalten in: European journal of endocrinology | 2023

von Hautefeuille, V. | Walter, T. | Do Cao, C. | +11

10

Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Bergen, E. | Pilla, L. | Auclin, E. | +21

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]